NeueHealth, Inc.
NEUE · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $61,037 | $65,621 | $409,136 | $2,162,707 |
| - Cash | $83,295 | $87,299 | $217,006 | $289,283 |
| + Debt | $204,614 | $370,347 | $350,058 | $155,000 |
| Enterprise Value | $182,356 | $348,669 | $542,188 | $2,028,424 |
| Revenue | $936,657 | $1,160,802 | $751,163 | $1,513,033 |
| % Growth | -19.3% | 54.5% | -50.4% | – |
| Gross Profit | $194,517 | $164,220 | $88,191 | $218,875 |
| % Margin | 20.8% | 14.1% | 11.7% | 14.5% |
| EBITDA | -$65,114 | -$566,800 | -$318,181 | -$308,578 |
| % Margin | -7% | -48.8% | -42.4% | -20.4% |
| Net Income | -$134,680 | -$1,151,454 | -$1,455,544 | -$1,184,862 |
| % Margin | -14.4% | -99.2% | -193.8% | -78.3% |
| EPS Diluted | -22.65 | -150.94 | -190.04 | -150.77 |
| % Growth | 85% | 20.6% | -26% | – |
| Operating Cash Flow | -$123,217 | -$2,726,546 | $234,466 | $82,059 |
| Capital Expenditures | -$2,333 | -$2,897 | -$27,448 | -$30,414 |
| Free Cash Flow | -$125,550 | -$2,729,443 | $207,018 | $51,645 |